NanoValent Pharmaceuticals, Inc. (NanoValent/NVP) is a privately-held company, collaborating closely with Children’s Hospital Los Angeles (CHLA) as well as other US academic partners. NanoValent possesses a highly experienced core management team with a proven track record of success, supported by a strong clinical and operational capability.